HHSE -- Sounds like they have locked down the merger and

New Post Public Reply Private Reply Replies (1) Message Board
ds22
418
HHSE -- Sounds like they have locked down the merger and the $65,000,000 in financing with more details to follow pre-market tomorrow.

Quote:
Sunday, April 16, 2017
Resolution of legal issues / concerns impacting new funding and structure for HHSE

Good Afternoon to HHSE Friends and Followers - Happy Easter, Happy Passover and Happy Sunday!

As forecasted within the year-end filing  (period ended 12-31-2016) certain legal issues impacting the structure and receipt of substantial new funding for HHSE were resolved as of last Friday (April 14).

Additional details on this venture - and the substantial premium it delivers to HHSE shareholders - will be released pre-market tomorrow. 


http://hannoverhousemovies.blogspot.com/


Here is the year end filing commenting on the merger and funding:

Quote:
Item 11 A1-A6 – Supplemental Disclosures.

i). In a subsequent development occurring after the applicable time period covered in this filing, the Company and another fully registered public equity have mutually executed a letter of intent agreement for a corporate merger which will have significant impact to the financial strength, operations, profile and activities of the Company. The merger – which has been contemplated as a stock-for-stock swap, with Hannover House, Inc. shareholders collectively maintaining a majority stock interest and control – is a key structural element to accommodate the placement of an initial $65-mm in production and distribution financing arranged for by the merger partner. The Company and merger partner anticipate that the merger shall become effective following certain regulatory compliances and the remittance of specified payments to Company – both of which events are anticipated to be resolved on or before April 14, 2017. Management feels that this proposed merger will provide an immediate and significant premium value to HHSE shareholders, as well as position the Company to fill the currently open market niche’ for a domestic studio focusing on high-quality, mid-level theatrical features (with movies of the budgetary cost and commercial appeal such as “Get Out”, “Little Miss Sunshine”, “Lion” – e.g., quality independent films with budgets of $3-mm to $7-mm and USA box office values approaching $100-mm). Corporate counsel has advised management that the Company shall be obligated to disclose the merger partner and principal terms of the merger at such time that the legality and logistics of this proposed merger structure are determined to be acceptable, which issues are currently under review and are anticipated to be resolved on or before April 14, 2017. Upon formal closure of this corporate merger, as presently
23

structured and anticipated by counsel and advisors, Company shall be a fully registered, fully reporting equity, with DTC approved stock trading and the opportunity to quickly uplist to NASDAQ.

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 177

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Updated Category News Views 73

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Continue Reading
Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 196

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 88

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Main Street Merger Faces Scrutiny: What It Means for Shareholders

Updated Category News Views 51

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Continue Reading
Everest Group Faces Class Action: Key Deadlines Looming

Updated Category News Views 79

Everest Group's Legal Quagmire: A Rocky Road Ahead Riding high has its pitfalls. I mean just take a gander at Everest Group, Ltd. (NYSE: EG). The suits and stocks got their knickers in a twist when the company's missteps saw them landing smack dab in the middle of a shareholder class-action lawsuit. It's gloomy days, my friend, especially if you're carrying a portfolio...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 118

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Updated Category News Views 68

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 33

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 74

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading

Top 5 Most Recently Viewed Articles

Investing Insights: Analyzing Entergy's Stock Trends

Updated Category News Views 222

Understanding Entergy's Short Interest Dynamics Entergy Corporation (NYSE: ETR) is making headlines with a notable change in its short interest. Recently reported figures indicate that short interest has decreased by 7.96%, now standing at approximately 6.98 million shares sold short. This accounts for 1.85% of all regular shares available for trading. Given the current...

Continue Reading
CoinShares Reports Strong Q1 2025 Performance Amid Market Challenges

Updated Category News Views 161

CoinShares Reports Strong Q1 2025 Performance Amid Market Challenges CoinShares International Limited (Nasdaq Stockholm: CS; USOTCQX: CNSRF), a leading global investment firm in digital assets, has unveiled its impressive results for the first quarter of 2025. Despite the volatility in digital asset prices, CoinShares has shown remarkable operational endurance and...

Continue Reading
Porsche's Unmatched Customer Loyalty Recognition in the Industry

Updated Category News Views 272

Porsche's Customer Loyalty Achievement Porsche has recently been recognized for the fourth consecutive year as the leader among luxury car owners in the prestigious J.D. Power U.S. Automotive Brand Loyalty Study. This study focuses on the loyalty of vehicle owners and whether they choose to purchase a new vehicle from the same brand after trading in their previous car....

Continue Reading
Siili Solutions Plc: Recent Holdings Notification Update

Updated Category News Views 119

Important Update on Shareholder Holdings from Siili Solutions Plc Siili Solutions Plc has recently shared significant updates regarding its shareholders, in accordance with the Finnish Securities Market Act. This announcement highlights changes in the ownership stakes of a major institutional investor. Date of Announcement and Context On 2 September 2024, the company...

Continue Reading
Tyra Biosciences Achieves Key Preclinical Results, Analysts Upgrades

Updated Category News Views 167

Tyra Biosciences Receives Analyst Upgrade BofA Securities has recently upgraded Tyra Biosciences (NASDAQ: TYRA), a clinical-stage biotechnology firm specializing in the creation of next-generation precision medicines. This upgrade highlights investor optimism as the company demonstrates promising results in its drug development process. Focus on Precision Medicine in...

Continue Reading